Financing channel feed – Endpoints News

Financing channel feed

ARCH backs lab instrument company that wants to help demystify how cells talk to each other

11 months ago

Oscar stakes its future on companies dumping worker health benefits

11 months ago

New obesity biotech Syntis Bio launches with early-stage alternative to GLP-1s

11 months ago

Alumis files for IPO ahead of Phase 3 studies for second-gen TYK2 inhibitor

11 months ago

UK medtech raises $100M for two-in-one urinary incontinence treatment

11 months ago

German radiopharma nabs €188M to boost isotope manufacturing, advance cancer pipeline

11 months ago

Radiopharmaceutical company Telix aims for $202M IPO

11 months ago

Novo Holdings’ head of Asia on investing in ‘China for China,’ and staying out of biotech (for now)

11 months ago

Exclusive: Inspired by Spinraza, startup raises $25M for cancer drug targets created by alternative RNA splicing

11 months ago

Australian life sciences VC Brandon Capital raises $180M for sixth fund

11 months ago

Rapport Therapeutics sets out for $122M Nasdaq debut as IPO backlog seeks fresh air

11 months ago

Joe Jimenez and Mark Fishman target $400M for third fund after leaving Novartis

11 months ago

CinRx raises $73M to create more biotechs, further support obesity drug development

11 months ago

New York startup raises $33M for fertility treatment based on George Church’s stem cell research

11 months ago

Canadian biotech VC Amplitude raises $192M second fund

11 months ago

Exclusive: SR One raises $200M+ for third fund, still with GSK support

11 months ago

Startup launches with ‘RNA sensor’ technology from Stanford and MIT to better control mRNA therapies

11 months ago

Grey Wolf reels in $50M to expand into autoimmune diseases

11 months ago

Versant has a new obesity biotech. AstraZeneca has the option to buy it

11 months ago

With a fresh $100M, Monte Rosa CEO details plans to move several molecular glues into the clinic

11 months ago

AltruBio secures $225M for an updated version of its ulcerative colitis drug

11 months ago

ADC biotech Pheon raises $120M to test three assets in the clinic

11 months ago

UK biotech raises £35M to develop solid tumor drugs based on machine learning

11 months ago

Progentos emerges with $65M for multiple sclerosis trials with IP from Frequency

11 months ago

First page Previous page 13 14 151617 18 19 Next page Last page